Winthrop Capital Management, LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 2010657 Carmel, IN

Position in PYXS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$18,060

+$9,300 QoQ

Shares Held

6,000

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#59

of 76 holders

Holding Since

Dec 2024

7 quarters on record

Healthcare · as of Jun 30, 2026

Winthrop Capital Management, LLC holds $265,432 across 6 Biotechnology names. PYXS ranks #4 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	856	$114,070
2	CGON	CG Oncology, Inc.	1,467	$104,230
3	VOR	Vor Biopharma Inc.	1,481	$27,265
4	PYXS	Pyxis Oncology, Inc. This page	6,000	$18,060
5	ALNY	Alnylam Pharmaceuticals, Inc.	6	$1,806
6	EXEL	Exelixis, Inc.	26	$1

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,060	6,000	0.0%	Shares	Sole	2026-08-13
2026-03-31	$8,760	6,000	0.0%	Shares	Sole	2026-04-28
2025-12-31	$6,900	6,000	0.0%	Shares	Sole	2026-02-10
2025-09-30	$13,320	6,000	0.0%	Shares	Sole	2025-11-13
2025-06-30	$6,600	6,000	0.0%	Shares	Sole	2025-08-07
2025-03-31	$5,880	6,000	0.0%	Shares	Sole	2025-05-06
2024-12-31	$9,360	6,000	—	Shares	Sole	2025-02-13
No filing history on record for this holder in this stock.